Postmenopause · Hormone Therapy
Is It Too Late to Start HRT After 60? What the Research Says About Timing
A lot of women in their 60s were told 20 years ago that hormone therapy was dangerous. Now they're reading that the guidance has changed, and they want to know: did I miss my chance?
The honest answer depends on your age, how long it's been since your final period, your health history and what you're hoping to treat. Here's how the timing question works.
The "window of opportunity"
When the Women's Health Initiative results came out in 2002, the average participant was 63, many years past menopause. Later analyses split the results by age. Women who started hormone therapy in their 50s had a much more favorable balance of risks and benefits than women who started in their 60s and 70s.
That's the basis of what's called the timing hypothesis. Current guidance reflects it:
- The Menopause Society's 2022 position statement says that for most healthy women with symptoms who are under 60 or within 10 years of menopause, the benefits of hormone therapy generally outweigh the risks.
- ACOG's October 2026 guideline also emphasizes timing, noting more benefit and lower risk when treatment begins before 60 or within 10 years of menopause.
- The American Heart Association reported that starting hormone therapy in that window was linked to lower heart disease risk.
What changes after 60
Starting systemic hormone therapy for the first time after 60, or more than 10 years after menopause, carries more risk. Older arteries may already have plaque, and estrogen may affect them differently. In the WHI Memory Study, women who started combined hormone therapy at 65 or older had a higher risk of dementia.
The risks of blood clots and stroke also rise with age. This is why route and dose matter so much later in life.
"Too late" isn't a hard line
Starting later doesn't automatically rule you out. It means the decision deserves more care. A woman who is 61 and three years past a late menopause is in a different place than a woman who is 68 and 18 years out. Factors that matter:
- Why you want it. Persistent hot flashes, sleep disruption and bone protection are different goals with different evidence.
- Your heart and clot risk. Blood pressure, ApoB, Lp(a), diabetes, smoking, personal or family history of clots, and sometimes a coronary calcium score.
- Breast cancer risk. Personal and family history and breast density.
- Route and dose. Transdermal estrogen (patch, gel or spray) and lower doses are associated with less risk of blood clots and stroke than pills.
Vaginal estrogen has no age limit
This is the part many women miss. Low-dose vaginal estrogen treats dryness, painful sex, urgency and recurrent UTIs, and very little reaches the bloodstream. The Menopause Society says it can be used at any age and for as long as needed. Many women who aren't good candidates for systemic therapy are good candidates for this. I cover it in my article on genitourinary syndrome of menopause.
Do you have to stop at 65?
No. The Menopause Society's 2022 statement says hormone therapy doesn't need to be routinely stopped at a certain age. It can be continued past 65 for persistent hot flashes, quality of life or bone protection, after a conversation about benefits and risks. A 2024 observational study of Medicare records found that women who used estrogen alone beyond 65 had lower rates of several outcomes, including death, breast cancer and dementia. Observational studies can't prove cause, but they're reassuring for women who are doing well on therapy.
The key is periodic review: is it still helping, and has anything in your health changed?
A functional medicine approach after 60
Whether or not hormones are part of your plan, the years after 60 are about protecting your heart, bones, brain and muscle:
- Strength training and protein to hold on to muscle and bone
- Cardiometabolic testing including ApoB, Lp(a), fasting insulin and HbA1c
- Bone density testing and attention to vitamin D, calcium from food and fall prevention
- Sleep, including screening for sleep apnea, which becomes much more common after menopause
- Non-hormonal relief for hot flashes when hormones aren't a fit. See my article on non-prescription hot flash relief.
The bottom line
Starting systemic HRT after 60 isn't forbidden, but it calls for a more careful, individual decision, ideally with transdermal estrogen at the lowest effective dose. Vaginal estrogen can be used at any age. And if you're already on hormone therapy and doing well, turning 65 isn't a reason to stop on its own.
If you're past 60 and weighing your options, my postmenopause and menopause care can help you think it through.
References
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353-1368. doi:10.1001/jama.2013.278040
- Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2003;289(20):2651-2662. doi:10.1001/jama.289.20.2651
- American College of Obstetricians and Gynecologists. Management of menopause-related vasomotor, sleep, and mood symptoms. Clinical Practice Guideline No. 13. Obstet Gynecol. 2026;148:e345-e369. ACOG news release
- El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506-e532. doi:10.1161/CIR.0000000000000912
- Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses. Menopause. 2024. The Menopause Society summary (observational study)